3D Printing Technology Over a Drug Delivery for Tissue Engineering
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jin Woo | - |
dc.contributor.author | Cho, Dong-Woo | - |
dc.date.available | 2020-02-28T14:45:36Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-04 | - |
dc.identifier.issn | 1381-6128 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11907 | - |
dc.description.abstract | Many researchers have attempted to use computer-aided design (CAD) and computer-aided manufacturing (CAM) to realize a scaffold that provides a three-dimensional (3D) environment for regeneration of tissues and organs. As a result, several 3D printing technologies, including stereolithography, deposition modeling, inkjet-based printing and selective laser sintering have been developed. Because these 3D printing technologies use computers for design and fabrication, and they can fabricate 3D scaffolds as designed; as a consequence, they can be standardized. Growth of target tissues and organs requires the presence of appropriate growth factors, so fabrication of 3Dscaffold systems that release these biomolecules has been explored. A drug delivery system (DDS) that administrates a pharmaceutical compound to achieve a therapeutic effect in cells, animals and humans is a key technology that delivers biomolecules without side effects caused by excessive doses. 3D printing technologies and DDSs have been assembled successfully, so new possibilities for improved tissue regeneration have been suggested. If the interaction between cells and scaffold system with biomolecules can be understood and controlled, and if an optimal 3D tissue regenerating environment is realized, 3D printing technologies will become an important aspect of tissue engineering research in the near future. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BENTHAM SCIENCE PUBL LTD | - |
dc.relation.isPartOf | CURRENT PHARMACEUTICAL DESIGN | - |
dc.title | 3D Printing Technology Over a Drug Delivery for Tissue Engineering | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000350281800010 | - |
dc.identifier.doi | 10.2174/1381612821666150115125324 | - |
dc.identifier.bibliographicCitation | CURRENT PHARMACEUTICAL DESIGN, v.21, no.12, pp.1606 - 1617 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84930903914 | - |
dc.citation.endPage | 1617 | - |
dc.citation.startPage | 1606 | - |
dc.citation.title | CURRENT PHARMACEUTICAL DESIGN | - |
dc.citation.volume | 21 | - |
dc.citation.number | 12 | - |
dc.contributor.affiliatedAuthor | Lee, Jin Woo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | 3D printing | - |
dc.subject.keywordAuthor | biomolecule | - |
dc.subject.keywordAuthor | drug delivery system (DDS) | - |
dc.subject.keywordAuthor | scaffold | - |
dc.subject.keywordAuthor | tissue engineering | - |
dc.subject.keywordPlus | CALCIUM-PHOSPHATE SCAFFOLDS | - |
dc.subject.keywordPlus | FREE-FORM FABRICATION | - |
dc.subject.keywordPlus | MICRO-STEREOLITHOGRAPHY | - |
dc.subject.keywordPlus | CERAMIC SCAFFOLDS | - |
dc.subject.keywordPlus | POLYMER SCAFFOLDS | - |
dc.subject.keywordPlus | DEPOSITION-SYSTEM | - |
dc.subject.keywordPlus | CELL-GROWTH | - |
dc.subject.keywordPlus | STEM-CELLS | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | SURFACE | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.